Literature DB >> 7592182

The in-vitro activity of biapanem against 964 clinical isolates of aerobic bacteria.

N J Raymond1, D A Bremner.   

Abstract

The in-vitro susceptibilities of 964 clinical isolates of aerobic bacteria to biapenem (a novel carbapenem), imipenem, ceftazidime and ciprofloxacin were determined by an agar dilution method. Compared with imipenem, biapenem exhibited greater activity against aerobic Gram-negative bacilli, similar activity against Neisseria meningitidis, Neisseria gonorrhoeae and Haemophilus influenzae and less activity against Gram-positive cocci.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592182     DOI: 10.1093/jac/35.5.681

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

Review 1.  Biapenem.

Authors:  Caroline M Perry; Tim Ibbotson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

3.  Biapenem versus meropenem in the treatment of bacterial infections: a multicenter, randomized, controlled clinical trial.

Authors:  Xiaohui Wang; Xiaoke Zhang; Zhiyong Zong; Rujia Yu; Xiaoju Lv; Jianbao Xin; Chaohui Tong; Qinglin Hao; Zhiqiang Qin; Ying Xiong; Hong Liu; Guohua Ding; Chengping Hu
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.